Does surgery for carpal tunnel syndrome improve outcomes? by Tudiver, Fred & Johnson, E. Diane
January 2003 (Vol. 52, No. 1) 
 Clinical Inquiries 
FROM THE FAMILY PRACTICE INQUIRIES NETWORK 
Does surgery for carpal tunnel 
syndrome improve outcomes? 
Fred  Tudiver,  MD 
Department of Family Medicine, East Tennessee State University  Johnson City 
E.  Diane  Johnson,  MLS 
Health Sciences Library, University of Missouri–Columbia 
Photocopy for your patients “What is carpal tunnel syndrome?” 
  EVIDENCE-BASED ANSWER 
Good evidence supports the use of surgery for carpal tunnel syndrome over nonsurgical therapies such as 
wrist splints, nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, occupational therapy, local 
steroid injections, work modification, and oral vitamin B6 (Grade of Recommendation: A, based on 
extrapolation from a systematic review of 1 randomized controlled trial [RCT], 1 additional recent RCT, and 2 
cohort studies). Surgery is likely worth the extra costs when conservative therapy (up to 3 months) fails to 
improve symptoms and return of function, because delayed surgery is as successful as surgery performed 
shortly after diagnosis. Closed endoscopic release and open release surgery are equally effective therapies for 
controlling symptoms (Grade of Recommendation: C, based on extrapolation from a systematic review of 
RCTs). However, whether endoscopic release results in more rapid regain of function and return to work is 
unclear. 
  EVIDENCE SUMMARY 
A recent Cochrane review based on only 1 RCT of 22 patients published in 1964 concluded that surgical 
treatment of carpal tunnel syndrome appears to be more effective than wrist splinting.1 A well-designed RCT of 
176 patients published since that Cochrane review stated that with regard to overall improvement of symptoms 
and function status, surgical treatment of carpal tunnel syndrome was more effective than wrist splinting 18 
months posttreatment.2 The investigators found that surgery resulted in worse short-term outcomes at 1 month 
follow-up (29% vs 42% success), but by 3 months the improvement in all outcomes was greater in the surgery 
group (80% vs 54% success). The number needed to treat (NNT) over 18 months was only 2 patients in the 
treatment-received (per protocol) analysis (92% vs 37% success) and 7 in the intention-to-treat analysis (90% 
vs 75% success). Patients in the conservative treatment group who underwent surgery after splinting had failed 
had a higher success rate after 18 months follow-up than patients who did not have surgery (94% vs 62% 
success rate; NNT = 3). 
One cohort study of 90 patients concluded that with respect to symptom control and return to function, open 
release surgery was as effective as local steroid injection at 1 month follow-up.3 However, at 4 to 6 months 
after the operation, surgery patients were found to have significantly improved symptom and function scores, 
with continued improvement compared with patients who received the steroid injection. One other cohort study 
of 429 patients found that surgery (open or closed endoscopic) was more effective with respect to symptom 
relief and functional status than various nonsurgical therapies (NSAIDs, splints, physical or occupational 
therapy, local steroid injections, work modification, or vitamin B6) at 30 months follow-up.4 In both cohort 
studies, the patients’ pretreatment symptom and functioning scores were worse in the surgery group than in 
the nonsurgical group. The investigators in the first study3 did not report controlling for these scores. In the 
second study,4 the authors controlled for functional status scores, but not for symptom severity. 
One recent systematic review of 14 RCTs comparing types of surgical therapies for carpal tunnel syndrome 
concluded that none of the alternative surgical procedures, including closed endoscopic release, appeared to 
give better symptom relief than open release; and that the evidence is conflicting as to whether endoscopic 
release results in earlier return to work or improved level of function.5 
  RECOMMENDATIONS FROM OTHERS 
The American Society of Plastic and Reconstructive Surgeons recommends surgical release in the following 
situations6: (1) failed or incomplete conservative therapy; (2) motor weakness or thenar atrophy; (3) lumbrical 
pattern symptoms (occur when the metacarpophalangeal joints are held at 90 degrees, eg, driving, letter 
writing, holding a magazine, pinching, using a small tool); (4) severe pattern on electrical studies (not defined); 
(5) space-occupying lesions requiring excision; (6) acute carpal tunnel syndrome with symptoms lasting longer 
than 6 to 8 hours; and (7) progressive or severe symptoms lasting longer than 12 months. The Society did not 
recommend one surgical procedure over another.  
CLINICAL COMMENTARY 
Maureen  O’Reilly Brown,  MD, MPH 
Swedish Family Medicine Residency ProgramSeattle, Washington 
In my practice, many patients have carpal tunnel syndrome and we regularly struggle with 
the question of whether and when to suggest surgical consultation. This review will make 
that struggle easier. With at least 33% of cases responding to splinting alone, an initial trial 
of conservative treatment seems appropriate for most patients. However, early surgical 
referral when a conservative approach has failed can now be easily justified, given the 
90% or better success rate with surgery. The authors also include guidelines from the 
American Society of Plastic and Reconstructive Surgeons, which may be helpful in 
selecting which patients should go directly to surgical release. 
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